Patent Baristas

Two new blogs are on the scene for keeping pace with biotechnology. OnBioVC OnBioVC, a new blog by veteran blogger Adam Rubenstein, is listed as “Your Source for BioScience Venture Capital Data.”  Headquartered in Boulder, Colorado, OnBioVC provides timely coverage and comprehensive analysis of global bioscience venture capital investment activity. Although heavy on the financial […]

Early stage valuation of drug development is complicated and often considered unnecessary given that standard valuation methods can lead to negative numbers.  Most early stage investors use the method known as “making it up” to value really early stage inventions. More than that, a large problem is that a company or university performing services early […]

In a search for the best of 2008 in the legal blogospshere, Blawg Review, is looking for which of the year’s 51 host presentations should be named the Blawg Review of the Year 2008.  We hosted Blawg Review #161 on Patent Baristas, the Memorial Day Edition of Blawg Review. There were many presentations this past […]

Last month, Abbott Laboratories was sued by Bayer AG’s HealthCare unit alleging that drugmaker Abbott Laboratories’ best-selling drug, the arthritis drug Humira, infringes on a Bayer patent.  (Bayer HealthCare LLC v. Abbott Laboratories, 08cv507, U.S. District Court for the Eastern District of Texas).  Bayer claims that Humira®, a recombinant human IgG1 monoclonal antibody specific for […]

Patents, trade secrets and confidentiality agreements are mere words on paper to the scientist, engineer or executive intent on deception and theft. And if you have outsourced your research and development efforts overseas to countries with unenforced intellectual property laws and cultural norms that ignore individual property rights, then the intent to deceive and thieve […]

James Greenwood, President & CEO of the Biotechnology Industry Organization (BIO), wrote an open letter to President-Elect Obama for his ideas on reform for the U.S. Patent and Trademark Office. With more than 1.2 million patent applications pending before its more than 6,000 examiners, there is a sense that something needs to give. Notably, the […]

Hal Wegner, former Director of the Intellectual Property Law Program and Professor of Law, George Washington University Law School and now Partner at Foley & Lardner, updated his list of the Top 10 Patent Cases. We’ll be keeping an eye on these and more in 2009: (1)  Lucent v. Gateway:   Where indirect infringement is found, […]